GRTS
$0.81
Revenue | $0.03Mn |
Net Profits | $-30.82Mn |
Net Profit Margins | -106268.97% |
Gritstone Oncology Inc’s revenue fell -97.81% since last year same period to $0.03Mn in the Q4 2023. On a quarterly growth basis, Gritstone Oncology Inc has generated -98.15% fall in its revenue since last 3-months.
Gritstone Oncology Inc’s net profit fell -0.51% since last year same period to $-30.82Mn in the Q4 2023. On a quarterly growth basis, Gritstone Oncology Inc has generated 19.82% jump in its net profits since last 3-months.
Gritstone Oncology Inc’s net profit margin fell -4499.29% since last year same period to -106268.97% in the Q4 2023. On a quarterly growth basis, Gritstone Oncology Inc has generated -4227.18% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.32 |
EPS Estimate Current Year | -0.32 |
Gritstone Oncology Inc’s earning per share (EPS) estimates for the current quarter stand at -0.32 - a 3.03% jump from last quarter’s estimates.
Gritstone Oncology Inc’s earning per share (EPS) estimates for the current year stand at -0.32.
Earning Per Share (EPS) | -0.26 |
Gritstone Oncology Inc’s earning per share (EPS) jumped 13.33% since last year same period to -0.26 in the Q4 2023. This indicates that the Gritstone Oncology Inc has generated 13.33% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-05-11 | -0.33 | -0.3 | 9.09% |
2024-03-05 | -0.33 | -0.26 | 21.21% |
2023-08-09 | -0.35 | -0.31 | 11.43% |
2023-11-08 | -0.33 | -0.33 | 0% |